Skip to main content
Return news list
Energy and Mitochondria 2026-09-22

L-Arginine and L-Citrulline: Dual-Amino Acid Synergy for Nitric Oxide Pathways and Endothelial Support

L-Arginine is the direct substrate for NO synthase, while L-Citrulline provides a longer-lasting source of NO by converting to arginine. Together, they significantly improve endothelial function (FMD) and exercise endurance, making them a core amino acid combination for vascular health in our Energy & Mitochondria series.

L-Arginine and L-Citrulline: Dual-Amino Acid Synergy for Nitric Oxide Pathways and Endothelial Support

Nitric oxide (NO) is a key gaseous signaling molecule produced by vascular endothelial cells. It activates soluble guanylate cyclase (sGC), raising cGMP levels to relax vascular smooth muscle and promote vasodilation. NO also inhibits platelet aggregation, reduces leukocyte adhesion, and modulates immune responses, making it a critical target for cardiovascular health and sports nutrition.

L-Arginine is the direct amino acid substrate for endothelial nitric oxide synthase (eNOS), which catalyzes NO synthesis by oxidizing L-arginine into NO and L-citrulline. Multiple randomized, double-blind, placebo-controlled trials demonstrate that daily supplementation with 3–6 g of L-arginine over 4–12 weeks significantly improves vascular endothelial function (flow-mediated dilation, FMD, improved by approximately 30–40%) and reduces both systolic and diastolic blood pressure.

However, L-arginine faces bioavailability challenges: it is partially degraded by arginase in the gut after oral administration and undergoes significant hepatic first-pass metabolism. L-citrulline, an upstream precursor of arginine, bypasses liver metabolism and is converted to arginine via the argininosuccinate pathway in the kidneys and vascular endothelium, providing a more sustained increase in plasma arginine levels. Studies show that daily intake of 3–6 g of L-citrulline boosts plasma arginine more effectively than an equivalent dose of arginine supplementation.

In functional medicine product development, the L-arginine + L-citrulline dual-amino acid combination delivers a synergistic "immediate NO generation + sustained substrate supply" solution. When paired with vitamin C (which prevents NO from oxidizing into peroxynitrite) and Coenzyme Q0 (to support endothelial mitochondrial function), it forms a complete vascular endothelial support formula. In sports nutrition, this can be combined with beta-alanine (a carnosine precursor for pH buffering) and creatine (for ATP buffering) to create a multi-pathway performance enhancement regimen.

Dynas Group (HK) offers a vascular health amino acid complex (L-arginine + L-citrulline + Vitamin C + Coenzyme Q0) in its Energy & Mitochondrial Series, available in capsule and powder OEM/ODM formats. The formula is designed around a comprehensive vascular support logic: NO generation + sustained substrate supply + endothelial protection.

Related Nutrients and Products

The following nutrients are relevant to this content and can be used for product formulation.

ViewEnergy & Mitochondria SeriesOEM Solutions
Omega-3 fatty acids
Immune Resilience

Omega-3 fatty acids

Omega-3 Fatty Acids (EPA/DHA)

EPA/DHA converts into resolvins and protectins, actively promoting the resolution of inflammation rather than simply suppressing it.

L-Arginine
Energy & Mitochondria

L-Arginine

L-Arginine

L-arginine is a substrate for nitric oxide (NO) synthase. It regulates endothelial vasodilation via the NO/cGMP pathway, supporting blood flow perfusion and blood pressure homeostasis. It also participates in ammonia clearance within the urea cycle and serves as a building block for protein synthesis.

L-Citrulline
Energy & Mitochondria

L-Citrulline

L-Citrulline

L-citrulline converts to L-arginine via the argininosuccinate pathway in the body, sustainably raising plasma arginine levels and supporting nitric oxide production. Unlike direct arginine supplementation, citrulline bypasses hepatic first-pass metabolism, offering higher bioavailability.